Literature DB >> 32542916

Habit reversal therapy in the management of body focused repetitive behavior disorders.

Jonathon Skurya1, Mohammad Jafferany1, Gregory J Everett1.   

Abstract

Body-focused repetitive behavior disorders are a group of disorders characterized by repetitive actions that include skin picking, hair pulling, nail biting, and other compulsions. These disorders can range from a common habit to a pathological disorder, that negatively impacts the psychiatric health and social well-being of an individual. Diagnosis can be made clinically, and monitored using different scales and assessments. Various treatments have been tried with differing successes. There are currently no first line curative medications for these disorders, but cognitive behavioral therapy has seen the most success in treatment. Specifically habit reversal therapy has shown the most promise in reducing the repetitive behaviors and symptoms seen in these disorders. Habit reversal therapy has also seen success through augmentation with additional therapies such as mindfulness, or treatment with a selective serotonin reuptake inhibitor in a patient with comorbid obsessive compulsive disorder. This paper aims to explore the efficacy of different treatment modalities specifically the effectiveness and approach of habit reversal therapy.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  BFRB; Habit reversal therapy; psychocutaneous disorders; psychodermatology

Mesh:

Year:  2020        PMID: 32542916     DOI: 10.1111/dth.13811

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

1.  Nail-Associated Body-Focused Repetitive Behaviors: Habit-Tic Nail Deformity, Onychophagia, and Onychotillomania.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2022-03-03

Review 2.  Update on Diagnosis and Management of Onychophagia and Onychotillomania.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Int J Environ Res Public Health       Date:  2022-03-13       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.